Publications by authors named "Thomas Cramer"

Claim this Profile
S
Skin-analogue primary poroid neoplasms of the head and neck with YAP1/WWTR1::MAML2/NUTM1 fusions: clinicopathologic and genetic spectrum of a novel tumor family delineated in a series of 10 cases.
Abbas Agaimy, Elan Hahn, Juan C Hernandez-Prera, Diana Bell, Yen Chen Kevin Ko, Thomas Cramer

Virchows Arch· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Lovastatin/Cholesterol as a Potential Field-Directed Therapy for Disseminated Superficial Actinic Porokeratosis: A Case Report.
Austin J Howe, Thomas J Singer, Thomas E Cramer

Cureus· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR3::TACC3 fusions in head and neck carcinomas: a study of nine cases highlighting phenotypic heterogeneity, frequent HPV association, and a morphologically distinct subset in favor of a putative entity.
Abbas Agaimy, Cristina R Antonescu, Diana Bell, Gerben E Breimer, Josephine K Dermawan, Thomas Cramer

Virchows Arch· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor.
Abbas Agaimy, Robert Stoehr, Lars Tögel, Arndt Hartmann, Thomas Cramer

Head Neck Pathol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanisms.
Annette von Drygalski, Vikas Bhat, Andrew J Gale, Patricia M Averell, Thomas J Cramer

Blood Adv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint Bleeding Tendencies in Adult Patients With Hemophilia: It's Not All Pharmacokinetics.
Jenny Y Zhou, Richard F W Barnes, Gary Foster, Alfonso Iorio, Thomas J Cramer

Clin Appl Thromb Hemost· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hypertension of hemophilia is associated with vascular remodeling in the joint.
Richard F W Barnes, Thomas J Cramer, Tudor H Hughes, Annette von Drygalski

Microcirculation· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study.
Richard F W Barnes, Thomas J Cramer, Afrah S Sait, Rebecca Kruse-Jarres, Doris V K Quon

Int J Hypertens· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.
Thomas J Cramer, Kristin Anderson, Karanjia Navaz, Justin M Brown, Laurent O Mosnier

Blood Cells Mol Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C.
Annette von Drygalski, Vikas Bhat, Andrew J Gale, Laurent Burnier, Thomas J Cramer

PLoS One· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular remodeling underlies rebleeding in hemophilic arthropathy.
Vikas Bhat, Merissa Olmer, Shweta Joshi, Donald L Durden, Thomas J Cramer

Am J Hematol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anticoagulant function of coagulation factor V.
Thomas J Cramer, Andrew J Gale

Thromb Haemost· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Function of the activated protein C (APC) autolysis loop in activated FVIII inactivation.
Thomas J Cramer, Andrew J Gale

Br J Haematol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.
Thomas J Cramer, John H Griffin, Andrew J Gale

Pathophysiol Haemost Thromb· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V.
Andrew J Gale, Thomas J Cramer, Diana Rozenshteyn, Jason R Cruz

J Biol Chem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis